WR-2721 PROTECTS AGAINST THE HEMATOLOGIC TOXICITY OF CYCLOPHOSPHAMIDE - A CONTROLLED PHASE-II TRIAL

被引：128

作者：

GLOVER, D

GLICK, JH

WEILER, C

HUROWITZ, S

KLIGERMAN, MM

机构：

[1] UNIV PENN,DEPT MED,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104

[2] UNIV PENN,DEPT RADIAT THERAPY,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104

[3] UNIV PENN,CTR CANC,PHILADELPHIA,PA 19104

来源：

JOURNAL OF CLINICAL ONCOLOGY | 1986年 / 4卷 / 04期

关键词：

D O I：

10.1200/JCO.1986.4.4.584

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：584 / 588

页数：5

相关论文

共 19 条

[11] A LIQUID-CHROMATOGRAPHIC ELECTROCHEMICAL ASSAY FOR S-2-(3-AMINOPROPYLAMINO) ETHYLPHOSPHOROTHIOATE (WR2721) IN HUMAN-PLASMA
SHAW, LM
BONNER, H
TURRISI, A
NORFLEET, AL
GLOVER, DJ
[J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1984, 7 (12): : 2447 - 2465
[12] WASSERMAN TH, 1981, CANCER CLIN TRIALS, V4, P3
[13] CLINICAL-TRIAL OF THE EFFECT OF S-2-(3-AMINOPROPYLAMINO)-ETHYLPHOSPHOROTHIOIC ACID (WR-2721) (NSC-296961) ON THE TOXICITY OF CYCLOPHOSPHAMIDE
WOOLLEY, PV
AYOOB, MJ
SMITH, FP
DRITSCHILO, A
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (03) : 198 - 203
[14] YUHAS JM, 1969, J NATL CANCER I, V42, P331
[15] TREATMENT OF TUMORS WITH THE COMBINATION OF WR-2721 AND CIS-DICHLORODIAMMINEPLATINUM (II) OR CYCLOPHOSPHAMIDE
YUHAS, JM
SPELLMAN, JM
JORDAN, SW
PARDINI, MC
AFZAL, SMJ
CULO, F
[J]. BRITISH JOURNAL OF CANCER, 1980, 42 (04) : 574 - 585
[16] YUHAS JM, 1980, CANCER RES, V40, P1519
[17] CIRCUMVENTION OF THE TUMOR MEMBRANE BARRIER TO WR-2721 ABSORPTION BY REDUCTION OF DRUG HYDROPHILICITY
YUHAS, JM
DAVIS, ME
GLOVER, D
BROWN, DQ
RITTER, M
[J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1982, 8 (3-4): : 519 - 522
[18] YUHAS JM, 1979, CANCER TREAT REP, V6, P971
[19] Yuhas JMS, 1980, RAD SENSITIZERS, P303